Updated Medicines in Practice document

8th Apr 2019

The updated medicines in practice document reviewing the cardiovascular outcomes associated with SGLT2 inhibitors is now online. This publication is specifically designed to support stakeholder Medicines Management services to maximise health gains through the optimum use of medicines by influencing and changing prescribing behaviour.